Skip Navigation


JAC Advance Access originally published online on May 15, 2006
Journal of Antimicrobial Chemotherapy 2006 58(1):133-139; doi:10.1093/jac/dkl190
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
58/1/133    most recent
dkl190v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Blanco, J. J. R.
Right arrow Articles by Rodríguez, J. J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blanco, J. J. R.
Right arrow Articles by Rodríguez, J. J. V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Endothelial function in HIV-infected patients with low or mild cardiovascular risk

Juan José Ríos Blanco1,*, Inés Suárez García1, Jorge Gómez Cerezo1, José María Peña Sánchez de Rivera1, Pilar Moreno Anaya2, Pilar García Raya2, Juan González García1, José Ramón Arribas López1, Francisco Javier Barbado Hernández1 and Juan José Vázquez Rodríguez1

1 Department of Internal Medicine, Hospital Universitario La Paz Madrid, Spain 2 Department of Radiology, Hospital Universitario La Paz Madrid, Spain

Received 17 January 2006; returned 28 February 2006; revised 13 April 2006; accepted 18 April 2006

*Corresponding author. Tel: +34-630064677; Fax: +34-917290033; E-mail: juanjo.rios{at}gmail.com

Background: Highly active antiretroviral therapy for HIV-infected patients is associated with metabolic side effects, which could cause an increased cardiovascular risk in these patients. Non-invasive study of endothelial function by brachial artery ultrasound can detect subclinical atherosclerosis. Several studies have assessed endothelial function in HIV-infected patients with associated cardiovascular risk factors.

Objectives: The aim of this study is to determine endothelial function in HIV-infected patients under antiretroviral therapy with low or mild coronary risk and lipid levels within the normal range.

Methods: Transversal study including 28 HIV-infected adults (15 receiving antiretroviral therapy and 13 naive) with low or mild cardiovascular risk and 12 healthy controls. Subjects with diabetes mellitus, hypertension, cardiovascular disease, obesity, high cholesterol or high triglyceride levels were excluded. Endothelial function was determined with flow-mediated dilation (FMD) of the brachial artery by ultrasound study.

Results: Treated HIV-infected patients had significantly lower FMD (5.93 ± 3.56) than healthy controls (10.64 ± 3.08, P = 0.008). Naive patients had an intermediate FMD, but this was not statistically significant.

Conclusions: HIV-infected patients receiving antiretroviral therapy who have low or mild cardiovascular risk and lipid levels within the normal range have endothelial dysfunction compared with healthy controls.

Keywords: atherosclerosis , risk factors , antiretroviral therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
F. J. Torriani, L. Komarow, R. A. Parker, B. R. Cotter, J. S. Currier, M. P. Dube, C. J. Fichtenbaum, M. Gerschenson, C. K.C. Mitchell, R. L. Murphy, et al.
Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s
J. Am. Coll. Cardiol., August 12, 2008; 52(7): 569 - 576.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
K. Samaras
Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection
J. Antimicrob. Chemother., February 1, 2008; 61(2): 238 - 245.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.